CIK 0001819411 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Gain Therapeutics, Inc.
Sign in to watch- Ticker
- GANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851726310
- Phone
- (301) 500-1556
- Business address
- 4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-21 | Alder Matthias Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +370,000 | 370,000 | ||
| 2023-12-21 | Alder Matthias Chief Executive Officer | Sale | −206 | $2.46 | $507 | 5,286 |
| 2023-12-20 | Alder Matthias Chief Executive Officer | Option exercise | +637 | 5,492 | ||
| 2023-12-20 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −637 | 7,013 | ||
| 2023-12-07 | Alder Matthias Chief Executive Officer | Sale | −1,820 | $2.50 | $5K | 4,855 |
| 2023-10-01 | Alder Matthias Chief Executive Officer | Option exercise | +825 | 6,675 | ||
| 2023-10-01 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −825 | 9,075 | ||
| 2023-09-20 | RICHMAN ERIC I Director | Option exercise | +54,900 | 272,629 | ||
| 2023-09-20 | RICHMAN ERIC I Director | Option exercise · Restricted Stock Units | −54,900 | 0 | ||
| 2023-09-20 | Alder Matthias Chief Executive Officer | Option exercise | +2,550 | 5,850 | ||
| 2023-09-20 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −2,550 | 7,650 | ||
| 2023-07-01 | Alder Matthias Chief Executive Officer | Option exercise | +3,300 | 3,300 | ||
| 2023-07-01 | Alder Matthias Chief Executive Officer | Option exercise · Restricted Stock Units | −3,300 | 9,900 | ||
| 2023-06-23 | Islam Khalid Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-06-23 | Riley Jeffrey Scott Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-06-23 | GOLDSTEIN DOV A MD Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-06-23 | Melincoff Gwen A Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-06-23 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-06-23 | HASLER HANS PETER Director | Grant or award · Stock Option (right to buy) | +10,500 | 10,500 | ||
| 2023-04-10 | Ballantyne Charles Evan Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 |
Page 3 of 5 · 88 trades